In the world of medical, dental, and veterinary practice transactions, late-stage deal friction is a familiar adversary. When a transaction slows, stalls, or collapses, the blame often falls on lenders, lawyers, or “unexpected” diligence issues. However, the true origins of most late-stage friction are rarely found in these final hurdles. Instead, they are embedded much earlier in the process—often in the very first decisions made by buyers, sellers, brokers, and advisors.

These early decisions, made in the spirit of efficiency or optimism, can quietly and inexorably narrow the path forward. By the time friction becomes visible—manifesting as retrades, delays, or even deal failure—the root causes are rarely new. They are the predictable consequences of choices made without full context, often under the pressure of momentum or the allure of a quick win.

Understanding how early financing, pricing, and structural decisions create late-stage friction is not just an academic exercise. It is a practical necessity for anyone involved in sophisticated practice transactions. These are not theoretical risks; they are recurring patterns that can be anticipated and, with the right approach, avoided.

The Hidden Cost of Early Decisions

At the outset of a healthcare transaction, optimism is abundant. Parties are motivated, timelines seem flexible, and risks appear manageable. In this environment, early decisions are often framed as provisional or easily revisited:

• “We can adjust the price later if needed.”
• “Financing should be fine, we’ll sort that out.”
• “Structure is a detail we can clean up after the LOI.”

In reality, these decisions are rarely as provisional as they seem. Once expectations are set—internally among deal teams and externally with counterparties—revisiting early assumptions becomes costly, both financially and relationally. Momentum hardens positions, and what should have been a simple refinement later in the process feels like a renegotiation. This is the point at which friction begins to build.

Late-stage friction, then, is not a failure of execution. It is a failure of sequencing. The seeds of conflict are sown early, and by the time they sprout, the options for resolution are limited and expensive.

Let’s examine the most common early-stage decisions that create late-stage friction in medical, dental, and veterinary practice transactions.

1. Pricing Decisions Made Without Financing Reality

One of the most frequent and consequential early missteps is agreeing on a purchase price before understanding how the healthcare transaction will be financed. In practice sales, pricing is not simply a function of market demand or negotiation prowess. It is fundamentally constrained by lender underwriting standards, cash flow coverage requirements, buyer liquidity, and the realities of post-closing debt service.

When pricing is discussed in isolation—without lender input or realistic financial modeling—it creates a fragile economic foundation. Sellers become anchored to a number, buyers commit emotionally, and brokers market the deal as a certainty. This dynamic is especially pronounced in competitive markets, where the pressure to “win” the deal can override prudent analysis.

Later, when lenders begin their underwriting process, they introduce constraints that were always present but never acknowledged. Coverage ratios may fail to meet minimum thresholds. Add-backs to EBITDA (earnings before interest, taxes, depreciation, and amortization) may be disallowed. Buyer income expectations may prove unrealistic in light of actual cash flows.

At this point, friction is unavoidable:

• Sellers feel the deal is being retraded, undermining trust.
• Buyers feel overextended, facing the prospect of higher equity contributions or less favorable terms.
• Advisors are forced into reactive problem-solving, often with limited room to maneuver.

The issue is not that lenders are difficult or capricious. It is that early pricing decisions ignored lending reality. The result is a deal structure that cannot survive contact with the real world of financing.

Practical Example

A dental practice is listed for $2 million based on recent comparable sales. The buyer and seller agree to this price, and a letter of intent (LOI) is signed. Only after the LOI is executed does the buyer approach lenders, who inform them that, based on the practice’s cash flow and the buyer’s financial profile, the maximum loan available is $1.6 million. The gap must be filled with additional equity or a price reduction. The seller, having anchored to $2 million, is resistant to renegotiation, and the deal stalls.

2. Financing Strategy Deferred Until After Economics Are Set

Closely related to the pricing issue is the tendency to treat financing as an administrative step—something the buyer will “handle” after price and structure are agreed. This approach assumes that lenders are passive participants in the process, simply providing funds on demand.

In reality, lenders are active stakeholders who influence:

• The maximum purchase price
• Required equity contributions
• Deal structure (e.g., asset vs. stock purchase)
• Closing timelines
• Risk allocation (e.g., personal guarantees, collateral)

When financing strategy is delayed, lenders are forced to react to decisions they did not help shape. Their reaction often introduces friction: revised terms, delayed approvals, or additional conditions. By the time this occurs, the deal team is already committed to a structure that may not survive underwriting intact.

Practical Example

A veterinary practice buyer negotiates a deal structure that includes a significant earn-out component, assuming it will be attractive to lenders. However, the lender’s policies prohibit earn-outs in practice acquisitions, requiring a fixed purchase price. The deal must be restructured, causing delays and frustration for all parties.

3. Structural Decisions Postponed as “Details”

Another common source of late-stage friction is the postponement of structural questions. Entity structure, post-closing employment arrangements, associate compensation, buy-in mechanics, and ownership transitions are often labeled as “details” to be addressed after the headline price is agreed.

The problem is that structure determines feasibility. For example, whether the healthcare transaction is structured as an asset sale or a stock sale has significant implications for tax treatment, regulatory compliance, and lender comfort. Post-closing employment arrangements can affect the retention of key personnel and the stability of revenue streams.

When structural issues are deferred, they resurface later—often during diligence or underwriting—when changes can affect tax treatment, lender comfort, or long-term economics. At that stage, even reasonable adjustments feel destabilizing. What could have been addressed cleanly early now threatens timelines and relationships.

Practical Example

A medical practice is sold as a stock sale to preserve certain contracts and licenses. During diligence, it is discovered that the buyer’s lender will only finance asset purchases due to liability concerns. The parties must renegotiate the structure, with potential tax consequences and delays.

4. Letters of Intent That Create False Certainty

Letters of intent (LOIs) play an outsized role in practice transactions. Although typically non-binding, LOIs establish expectations that are psychologically binding. Price, timelines, and certainty become assumed, even when critical assumptions remain untested.

When LOIs are executed before financing, real estate, and structural considerations are aligned, they lock in expectations prematurely. Adjustments later feel like backtracking rather than clarification. This is especially problematic in medical, dental, and veterinary practice transactions, where third-party approvals (lenders, landlords, regulators) materially affect outcomes.

Late-stage friction arises because certainty was created before certainty was warranted. The parties feel committed to terms that may not be achievable, and any deviation is perceived as a breach of trust.

Practical Example

A dental practice LOI is signed with a 60-day closing timeline, assuming landlord approval for lease assignment will be routine. The landlord, however, requires extensive financial disclosures and imposes new conditions, delaying the process. The seller grows impatient, and the buyer feels pressured, leading to tension and potential deal failure.

5. Diligence Sequenced for Speed Instead of Risk

Early diligence decisions often prioritize speed. To maintain momentum, diligence may be under-scoped or launched without prioritization. All items are treated equally, rather than sequenced by lender sensitivity and deal risk.

As a result:

• Critical issues surface late, when options for resolution are limited.
• Minor issues consume early attention, diverting resources from more significant risks.
• Timelines compress unnecessarily, increasing pressure on all parties.

When meaningful diligence findings appear late, they are no longer inputs to the process. They become obstacles. Negotiations become reactive, and leverage shifts unpredictably. Deals do not unravel because diligence reveals risk; they unravel because it reveals risk too late.

Practical Example

A veterinary practice buyer focuses early diligence on equipment inventory and patient records, assuming regulatory compliance is a given. Only late in the process does a review of licensing reveal a pending investigation by the state veterinary board, jeopardizing lender approval and the entire transaction.

6. Advisors Introduced After Commitments Are Made

Another early decision with predictable consequences is delaying advisor involvement. When legal, financial, or strategic advisors are brought in after price, structure, and timelines are agreed, their role becomes constrained. Instead of shaping the healthcare transaction, they are asked to document it or fix problems created earlier.

This creates friction in two ways:

• Advisors surface issues that were always present but now feel disruptive.
• Solutions are limited because flexibility has already been surrendered.

Late-stage friction often reflects tension between what was promised early and what is workable later. The expertise of advisors is most valuable when it is applied early, before commitments are made.

Practical Example

A medical practice seller negotiates a deal directly with a buyer, agreeing to terms that seem reasonable. When the seller’s attorney is finally engaged, they identify significant regulatory and tax issues with the proposed structure. The buyer resists changes, feeling the deal is being altered, and trust erodes.

7. Real Estate Treated as Secondary

In  healthcare transactions, real estate is frequently treated as an afterthought. Lease assignments, landlord approvals, rent adjustments, and purchase options are addressed after deal economics are agreed, assuming real estate will cooperate.

When it does not, friction escalates quickly. Lenders may delay approvals pending lease assignments. Sellers may resist concessions required by landlords. Buyers may lose confidence in the deal’s viability. Closing timelines slip, and the risk of deal failure increases.

These outcomes are not surprises. They are the result of early decisions to deprioritize real estate.

Practical Example

A dental practice is sold with the expectation that the buyer will assume the existing lease. The landlord, however, requires a significant rent increase and a personal guarantee from the buyer. The economics of the deal are undermined, and the buyer seeks a price reduction, leading to conflict.

8. Timelines Set Before Risk Is Mapped

Aggressive timelines are often set early to create urgency. While urgency can be useful, it can also mask risk. When closing dates are established before financing, diligence, regulatory, and third-party risks are mapped, they incentivize shortcuts. Those shortcuts surface later as unresolved issues, lender hesitation, or rushed negotiations.

Late-stage friction emerges because the timeline was aspirational rather than grounded in transaction reality. The pressure to meet arbitrary deadlines can lead to poor decision-making and increased stress for all parties.

Practical Example

A veterinary practice transaction is scheduled to close in 45 days to accommodate the seller’s retirement plans. In the rush to meet this deadline, key diligence items are overlooked, and lender approval is delayed. The closing is missed, and the seller’s trust in the process is damaged.

How Early Decisions Compound Into Late-Stage Friction

Each of these early decisions may appear reasonable in isolation. The problem is cumulative. Pricing assumptions interact with financing constraints. Structural deferrals collide with diligence findings. Compressed timelines amplify every unresolved issue.

By the time friction is visible, optionality is gone. Concessions feel personal. Trust erodes. Even experienced participants struggle to recover momentum. At that stage, deals may still close, but often under worse terms, higher costs, and unnecessary strain.

Cumulative Example

Consider a medical practice sale where the price is set without lender input, the structure is left vague, the LOI is signed with an aggressive timeline, and advisors are brought in late. Each decision alone might be manageable, but together they create a cascade of issues: lender-imposed price reductions, structural changes with tax implications, delayed approvals, and mounting frustration. The deal closes, but only after significant concessions and damaged relationships.

Why This Matters for Sophisticated Practice Transactions

Sophisticated medical, dental, and veterinary practice transactions are not defined by the absence of friction. They are defined by how friction is anticipated and managed. Early decisions should:

• Reduce uncertainty, not defer it.
• Preserve flexibility, not trade it for speed.
• Align expectations with reality.

The most effective deal teams understand that early clarity prevents late conflict, and that sequencing determines leverage. By involving lenders, advisors, and key stakeholders early, and by sequencing decisions in a logical, risk-aware manner, deal teams can preserve optionality and maintain trust throughout the process.

Conclusion: Friction Is Predictable

Late-stage deal friction is not random. It is the predictable outcome of early decisions made without full context. When early financing, pricing, and structural decisions are informed by lending reality, sequencing discipline, and experienced advisory input, transactions tend to close smoothly, even when challenges arise. When they are not, friction is inevitable.

For buyers, sellers, brokers, bankers, and advisors involved in medical, dental, and veterinary practice transactions, the lesson is clear: invest in early-stage discipline. Map risks, involve key stakeholders, and ground decisions in reality. The cost of early diligence and thoughtful sequencing is far less than the cost of late-stage friction.

About Morgan Advisory Group

Morgan Advisory Group represents sophisticated medical, dental, and veterinary practice owners, investors, and professional partners in complex healthcare transactions. The firm provides legal, financial, and strategic guidance designed to align early decisions with downstream realities and protect deal outcomes.

Schedule a transaction review to evaluate early-stage decisions before they create late-stage friction.

By understanding and addressing the root causes of late-stage friction, all parties can achieve better outcomes, preserve relationships, and ensure that transactions deliver the intended value. In the high-stakes world of practice sales, early decisions are not just preliminary—they are determinative.